As PFK-1 sustains an increased glycolysis rate, an overexpression of PFK-1 was detected in several cancers such as breast cancer, ascites tumors, glioblastoma, B cell, and T cell leukemias, in which PFKP was identified as the predominant isoform [85]. This evidence concerns the gene PFKM and T-cell leukemia.